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Abstract
Introduction: Thrombocytopenia is one of the protean hematological manifestations of infection
by human immunodeficiency virus. We present a case where diagnosis of human immunodeficiency
virus infection was delayed because thrombocytopenia was the only presenting feature.
Case presentation: A female presented with chief complaint of fever, productive coughs weight
loss and nocturnal sweating; was detected to have thrombocytopenia on a complete blood count,
performed five months ago. Her other clinical chemistry and hematological investigations were
normal. She was previously diagnosed as having TTP, and had received 55 sessions of plasma
exchange before presenting to us. At this time she was detected to be HIV positive, had CD4+
counts of 26/mm3, treated with antiretroviral drugs and Cotrimoxazol, and discharged
asymptomatically.
Conclusion: HIV should be suspected in all cases of unexplained thrombocytopenia.
Introduction
Hematological manifestations of human immunodefi-
ciency virus (HIV) infection have a broad spectrum, rang-
ing from mild disturbance in quality of life to life-
threatening conditions [1]. Here, we present a case with
thrombocytopenia where diagnosis of HIV infection was
missed on initial evaluation.
Case presentation
A 29-year-old Iranian female, presented to infectious dis-
ease services with chief complaints of recurrent fever since
past five months and productive cough, of 20 days dura-
tion. Five months ago, while being evaluated for fever her
complete blood count (CBC) had revealed thrombocyto-
penia. For evaluation of thrombocytopenia, a bone mar-
row examination was done which showed erythroid
hyperplasia. A provisional diagnosis of thrombotic
thrombocytopenic purpura was made, and the patient
underwent 55 sessions of plasma exchange, over next two
months. Her fever had subsided by this time. Three
months later (five months after onset of her initial symp-
toms), she presented with fever, nocturnal sweats, produc-
tive cough, weight loss, weakness and generalized aches
and pains, productive coughs. Her body temperature was
39°C, Pulse rate: 108, Blood Pressure: 110/70 mmHg. On
physical examination, she had pale sclera, oral thrush,
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neck stiffness, crackles on lung fields, hepatosplenomeg-
aly and tender right upper quadrant of abdomen. A repeat
CBC showed pancytopenia (WBC: 2400/μl with 66%
PMN, 34% Lymph, Hb:5.6 g/dl, PLT:64800/μl),
ErythrocyteSedimentationRatewas68.BUN/Cr, hap-
toglubolin and billirubin (total, direct and indirect) were
in the normal range.
Coomb's test was also negative. On reviewing the history
again we found that four years ago patient's sexual partner
was an intravenous drug user. This prompted us to do an
HIV test in her, which was found to be positive. Her CD4
counts were low (26/mm3). Subsequently we performed
a bone marrow biopsy and bone marrow aspiration,
which were normal. Her cerebral spinal fluid analysis was
normal with negative smear and culture. Abdominal
ultrasonography showed hepatosplenomegaly and pres-
ence of a renal stone. Bilateral para-hilar infiltrations were
seen on chest X-ray. Broncho-Alveolar Lavage smear was
positive for Pneumocystis Jirovecii antigen. Antiretroviral
drugs (Zidovudine, Lamivudine and Nelfinavir) were
started in combination with Trimethoprim-Sulfamethox-
azole for the patient. Her fever subsided and was dis-
charged with a diagnosis of HIV associated
thrombocytopenia. On follow up her platelet counts
improved (WBC: 3500/μl) with 62% PMN, 38% Lymph,
Hb: 9.0 g/dl, PLT: 105000/μl, CD4: 102/mm3) and
lesions on her chest x-ray resolved.
Discussion
Increasing the complexity of HIV infection, different
hematological manifestations can be seen [1], in which
HIV-related thrombocytopenia (Tr-HIV) is one of them
[2], often asymptomatic [3], but may be associated with a
variety of bleeding abnormalities [4] and with a high mor-
bidity [2]. Despite of the common prevalence of HIV-
induced thrombocytopenia [5], profound thrombocyto-
penia is totally rare (1.5%) [6]. This problem is truly a
medical challenge in vulnerable population, especially by
the limited therapeutic options and the absence of inter-
vention protocol for HIV subjects [7]. It's not age and sex
dependent and interestingly [2], in contrast with anemia
and neutropenia [9], even it's not dependent to the stage
of infection [2]. Different mechanisms were described for
this, but the two most common ones are rapid destruction
by circulating immune complexes (especially profound
ones) [3], and insufficient production (especially in mild
ones) [2]. But, some other rare causes are also described as
TTP [9]. Although knowing the exact mechanism in each
patient seems difficult, diagnosis of the mechanisms and
causes of the thrombocytopenia seems necessary for the
optimal management of the patient [8]. For example in
the cases of immune-mediated thrombocytopenia a com-
bination of zidovudine, corticosteroids, IVIG, splenec-
tomy and some times platelet transfusion may be helpful
[8]. TPO, although investigational, is useful for the cases
of decreased platelet production [10], and plasmaphresis
for the cases conflicted by TTP, are used effectively [11].
Some other modalities, such as interferon, vincristine,
danazol, low-dose splenic irradiation and staphylococcal
protein A and immunoabsorption have been used with
limited success [12]. But it's well understood that HIV-
related thrombocytopenia (HIV-TP) responds to antiret-
roviral therapy [13] and most studied have shown that
zidovudine (AZT) increased platelet production, espe-
cially in combination therapy (ART) [14].
By the presence of great mimickers, the real face of HIV
induced thrombocytopenia may be masked in different
situations, as our case, in which the diagnosis of TTP was
made for her. HIV is one of the causes of TTP, especially in
the late stages [10], and plasmaphresis is also a good ther-
apeutic option [11]. Ignoring the complications of misdi-
agnosis for the patient, the role of plasmaphresis facilities
in AIDS epidemic, especially in developing countries [15],
is not negligible.
It is not clear why the first clinician diagnosed TTP, not
ITP for the patient, only based on the fever and thrombo-
cytopenia. And our message is the value of considering
HIV as a cause of thrombocytopenia seems a matter needs
more attention than paid previously, especially in devel-
oping countries. As a suggestion, taking an HIV test may
increase the plasma exchange safety for healthy persons
undergoing.
Conclusion
Hence HIV positive cases are increasing, especially in the
developing countries; consequently, the great clinical sus-
picion is needed to consider it as a cause of thrombocyto-
penia. The importance of this matter is not only from
diagnostic and therapeutic aspects, but also ethical con-
cerns behind; non HIV cases who undergo plasma
exchange. So, the significant role of proper history taking
will become elucidate once again.
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